NorthWest Biotherapeutics Inc (NWBO)

[791branko]

Beartrap12,
The FOR vote was the catalyst for our price reversal, your post was its trigger.
NWBO now has the capacity and flexibility to raise the funds necessary to complete their L trial. Without this capacity our future would have been much riskier, maybe even forcing NWBO to unblind prematurely. So moving forward the last remaining obstacle that can cause our demise is poor trial data which is a good place for our investment to be at.

Our price leading to the vote fell some 50% from recent highs of $0.34 to $0.17. Perhaps the recline factored the impeding dilution from our share count increase and some financial risk from a possible AGAINST vote.
Now that the Vote risk is gone and dilution possibly already factored our price is reversing imo.

Almost all large shareholders I know did not trade their shares leading into the vote. I believe we have a strong retail investor base that will serve us well. With eventual positive results our price can rise quickly.

Novocure, with their GBM device treatment, enjoy a multi Billion market cap while we sit under $100M.
Once the markets recognise DCVax-L can provide similar or better efficacy to Novocure they will move us quickly towards a similar cap.
From my modeling work I am confident L can at least equal Novocure’s efficiency.